BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4009507)

  • 1. Decreased fractional renal excretion of gentamicin in subtotal nephrectomized dogs.
    Riviere JE; Bowman KF; Rogers RA
    J Pharmacol Exp Ther; 1985 Jul; 234(1):90-3. PubMed ID: 4009507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration profiles: increased sensitivity in subclinical renal dysfunction.
    Frazier DL; Dix LP; Bowman KF; Thompson C; Riviere JE
    J Pharmacol Exp Ther; 1986 Dec; 239(3):946-51. PubMed ID: 3795053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal handling of gentamicin by normal and ischemic canine kidneys.
    Adelman MH; Harrison NJ; Wels PB; Schentag JJ
    J Lab Clin Med; 1982 Aug; 100(2):201-10. PubMed ID: 7097107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs.
    Frazier DL; Aucoin DP; Riviere JE
    J Am Vet Med Assoc; 1988 Jan; 192(1):57-63. PubMed ID: 3343180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. I. Subtotal surgical nephrectomy.
    Carver MP; Shy-Modjeska JS; Brown TT; Rogers RA; Riviere JE
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):251-63. PubMed ID: 4024115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary protein conditioning on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF; Greco DS; Behrend EN; Fettman MJ; Jaenke RS; Allen TA
    Am J Vet Res; 1994 Jan; 55(1):90-7. PubMed ID: 7908183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose response studies of gentamicin nephrotoxicity in rats with experimental renal dysfunction. III. Effects of dosage adjustment method.
    Rogers RA; Hanna AY; Riviere JE
    Res Commun Chem Pathol Pharmacol; 1987 Sep; 57(3):301-11. PubMed ID: 3671882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
    Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic implications of gentamicin accumulation in severly diseased kidneys.
    Whelton A; Carter GG; Bryant HH; Fox L; Walker WG
    Arch Intern Med; 1976 Feb; 136(2):172-7. PubMed ID: 2129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical status, renal function, and hematopoietic variables after unilateral nephrectomy in canine kidney donors.
    Urie BK; Tillson DM; Smith CM; Brawner WR; Almond GT; Beard DM; Lenz SD; Lothrop CD
    J Am Vet Med Assoc; 2007 Jun; 230(11):1653-6. PubMed ID: 17542732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
    Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
    Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and comparative nephrotoxicity of fixed-dose versus fixed-interval reduction of gentamicin dosage in subtotal nephrectomized dogs.
    Riviere JE; Carver MP; Coppoc GL; Carlton WW; Lantz GC; Shy-Modjeska J
    Toxicol Appl Pharmacol; 1984 Sep; 75(3):496-509. PubMed ID: 6474477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of aminoglycoside nephrotoxicity (author's transl)].
    Whelton A
    Nouv Presse Med; 1978 Nov; 7(42):3838-43. PubMed ID: 714689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tubular transport of gentamicin in the rat.
    Pastoriza-Munoz E; Bowman RL; Kaloyanides GJ
    Kidney Int; 1979 Oct; 16(4):440-50. PubMed ID: 548590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
    Zager RA; Baltes LA
    J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of gentamicin in the juvenile dog.
    Riviere JE; Coppoc GL
    Am J Vet Res; 1981 Sep; 42(9):1621-3. PubMed ID: 7325472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transport of netilmicin in the rat.
    Pastoriza-Munoz E; Timmerman D; Kaloyanides GJ
    J Pharmacol Exp Ther; 1984 Jan; 228(1):65-72. PubMed ID: 6694109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.